Benign Conditions

Benign Prostatic Hyperplasia

Bladder Cancer

Female Urology

Genitourinary Cancers

Genomic Testing

Hormone Therapy

Kidney Cancer

Challenging Anatomy

Innovative Techniques

Laser Lithotripsy

PCNL Tech & Devices

Ureteroscopy Tech & Devices

Kidney Stones

Men's Health

Next-Generation Imaging

Voiding Dysfunction

OAB and Incontinence

Pediatrics

Controveries in Urologic Cancer

Drug Therapy

Prostate Cancer

Sexual Dysfunction

UTUC

Cosmetic Surgery

Urologic Surgery

Business

Practice Management

Malpractice Consult

Health Law & Policy

Media

Case-Based Peer Perspectives

Investigator Perspectives 

Medical World News

Podcasts

Urology Medical Perspectives

UTv Videos

Peer Exchange

Virtual Tumor Board

Insights

Peers & Perspectives

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

CME/CE

Resources

Begin Your Journey: Tackling Burnout

Interactive Tools

Job Board

Partners

Subscribe

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times | News & Insights for Urologists & Health Professionals

Facebook

Twitter

LinkedIn

Spotlight

Peers and Perspectives

Clinical

1rem

View

Advances in Minimally Invasive Treatment Options for Benign Prostatic Hyperplasia

Closing

Video content above is prompted by the following:

How do minimally invasive surgical therapies (MIST) options fit into the evolving landscape of treatments for benign prostate dysplasia; why should urologists consider MIST options for their patients?

What unmet needs remain in the treatment of BPH, and are there any current trials/investigations in these topics?

Videos

Dean Elterman, MD, explores the latest advancements in minimally invasive treatment options for benign prostatic hyperplasia (BPH), detailing emerging techniques and their impact on patient care

Dean Elterman, MD, discusses historical treatment options for BPH, including both pharmacotherapy and surgical methods, their effectiveness, and how to identify patients who would benefit from treatment based on quality of life, risk of lower urinary tract symptoms, and other factors. It also addresses challenges such as long-term complications and patient adherence.





Comprehensive Insights into the Historical and Modern Treatment Strategies for BPH

Dean Elterman, MD, covers minimally invasive surgical therapies (MIST) for BPH, including laser therapy, prostatic urethral lift, and others, their impact on BPH management, AUA guidelines, patient selection, and the role of patient preference in choosing between MIST, medication, and surgery.





Advancements in MIST for BPH: Options, Guidelines, and Patient-Centered Decision-Making

Dean Elterman, MD, compares minimally invasive surgical therapy (MIST) options for prostate treatment, discussing factors influencing choice, patient experience differences, and clinical and nonclinical factors such as prostate size, symptom severity, and patient preferences.





Optimizing BPH Management: Evaluating MIST Options and Key Treatment Considerations

Dean Elterman, MD, discusses real-world outcomes of minimally invasive surgical therapies for benign prostate dysplasia, including improvements in quality of life, symptom relief, comparisons with clinical study results, and general patient feedback, while also sharing tips for building rapport and educating patients on their treatment options.




Real-World Treatment of BPH: Outcomes and Patient Education

Dean Elterman, MD, discusses how a comprehensive approach to diagnosing and managing benign prostatic hyperplasia (BPH) involves a combination of symptom assessment, lifestyle modifications, pharmacotherapy, and regular follow-up to optimize patient outcomes.




Case Study: Diagnosing and Managing BPH in a Male Patient With Urinary Symptoms

Dean Elterman, MD, discusses how minimally invasive surgical therapies (MIST) are increasingly integrated into the treatment landscape for benign prostatic hyperplasia (BPH), addressing unmet needs and offering new options, while also highlighting ongoing trials and investigations that aim to further refine these approaches.




Closing

EP: 1.Comprehensive Insights into the Historical and Modern Treatment Strategies for BPH

EP: 2.Advancements in MIST for BPH: Options, Guidelines, and Patient-Centered Decision-Making

EP: 3.Optimizing BPH Management: Evaluating MIST Options and Key Treatment Considerations

EP: 4.Real-World Treatment of BPH: Outcomes and Patient Education

EP: 5.Case Study: Diagnosing and Managing BPH in a Male Patient With Urinary Symptoms

EP: 6.Closing